261 related articles for article (PubMed ID: 32799852)
1. Implications of AB0 blood group in hypertensive patients with covid-19.
Sardu C; Marfella R; Maggi P; Messina V; Cirillo P; Codella V; Gambardella J; Sardu A; Gatta G; Santulli G; Paolisso G
BMC Cardiovasc Disord; 2020 Aug; 20(1):373. PubMed ID: 32799852
[TBL] [Abstract][Full Text] [Related]
2. Implications of ABO blood group in hypertensive patients with covid-19.
Sardu C; Marfella R; Maggi P; Messina V; Cirillo P; Codella V; Gambardella J; Sardu A; Gatta G; Santulli G; Paolisso G
Res Sq; 2020 Aug; ():. PubMed ID: 32818207
[No Abstract] [Full Text] [Related]
3. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
Panigada M; Bottino N; Tagliabue P; Grasselli G; Novembrino C; Chantarangkul V; Pesenti A; Peyvandi F; Tripodi A
J Thromb Haemost; 2020 Jul; 18(7):1738-1742. PubMed ID: 32302438
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J
J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
Wanderer JP; Nathan N
Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
[No Abstract] [Full Text] [Related]
7. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
Thachil J; Longstaff C; Favaloro EJ; Lippi G; Urano T; Kim PY;
J Thromb Haemost; 2020 Sep; 18(9):2408-2411. PubMed ID: 32881272
[No Abstract] [Full Text] [Related]
8. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
[TBL] [Abstract][Full Text] [Related]
9. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
Ranucci M; Ballotta A; Di Dedda U; Baryshnikova E; Dei Poli M; Resta M; Falco M; Albano G; Menicanti L
J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 update: Covid-19-associated coagulopathy.
Becker RC
J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
[No Abstract] [Full Text] [Related]
11. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
[TBL] [Abstract][Full Text] [Related]
12. Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy.
Sardu C; Maggi P; Messina V; Iuliano P; Sardu A; Iovinella V; Paolisso G; Marfella R
J Am Heart Assoc; 2020 Sep; 9(17):e016948. PubMed ID: 32633594
[TBL] [Abstract][Full Text] [Related]
13. The unique characteristics of COVID-19 coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
[TBL] [Abstract][Full Text] [Related]
14. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes.
Ronderos Botero DM; Omar AMS; Sun HK; Mantri N; Fortuzi K; Choi Y; Adrish M; Nicu M; Bella JN; Chilimuri S
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2764-2775. PubMed ID: 32907371
[TBL] [Abstract][Full Text] [Related]
16. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
Speed V; Patel RK; Byrne R; Roberts LN; Arya R
Thromb Res; 2020 Aug; 192():73-74. PubMed ID: 32425265
[No Abstract] [Full Text] [Related]
17. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
[TBL] [Abstract][Full Text] [Related]
18. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
[TBL] [Abstract][Full Text] [Related]
19. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.
Zhang L; Yan X; Fan Q; Liu H; Liu X; Liu Z; Zhang Z
J Thromb Haemost; 2020 Jun; 18(6):1324-1329. PubMed ID: 32306492
[TBL] [Abstract][Full Text] [Related]
20. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
